Citigroup initiated coverage of Enact Holdings with a rating of Buy and set a new price target of $24.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/6/2023 | $29.00 | Neutral | UBS |
| 11/13/2023 | $30.00 | Neutral → Buy | BofA Securities |
| 5/9/2023 | $25.00 → $27.00 | Underperform → Neutral | BofA Securities |
| 2/8/2023 | $25.00 → $26.50 | Mkt Perform → Outperform | Keefe Bruyette |
| 1/9/2023 | $24.50 | Neutral → Underperform | Credit Suisse |
| 9/6/2022 | $27.00 | Overweight → Neutral | JP Morgan |
| 8/18/2022 | $25.00 | Neutral → Underperform | BofA Securities |
| 7/18/2022 | $28.00 → $27.00 | Outperform → Mkt Perform | Keefe Bruyette |
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
SC 13G/A - Enact Holdings, Inc. (0001823529) (Subject)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
10-Q - Enact Holdings, Inc. (0001823529) (Filer)
8-K - Enact Holdings, Inc. (0001823529) (Filer)
RALEIGH, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 4, 2025. Enact will host a conference call to review fourth quarter 2024 financial results on February 5, 2025 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to
Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 18, 2025. A conference call will be held on February 19, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 19 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #5461958. To participat
RALEIGH, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact), a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its flagship legal entity, Enact Mortgage Insurance Corporation, has entered into two quota share reinsurance agreements with a broad panel of highly-rated reinsurers. Under the agreements, and subject to certain conditions, Enact will cede approximately 27% of a portion of expected new insurance written for the period from January 1, 2025 through December 31, 2025 and will cede approximately 27% of a portion of expected new insurance written for the period from January 1, 2026 through December
RALEIGH, N.C., Jan. 09, 2025 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (NASDAQ:ACT) (Enact) announced it will issue its fourth quarter earnings release after the market closes on February 4, 2025. Enact will host a conference call to review fourth quarter 2024 financial results on February 5, 2025 at 8:00 a.m. (ET). Enact's earnings release, summary presentation and financial supplement will be available through the company's website, https://ir.enactmi.com/, at the time of their release to the public. Participants interested in joining the call's live question and answer session are required to pre-register by clicking here to obtain a dial-in number and unique PIN. It is recommended to
Genworth Financial, Inc. (NYSE:GNW) today announced it will issue its earnings release containing fourth quarter results after the market closes on February 18, 2025. A conference call will be held on February 19, 2025, at 9:00 a.m. (ET) to discuss the quarter's results. Genworth's earnings release, summary presentation and financial supplement will be available through the company's website, http://investor.genworth.com, at the time of their release to the public. Genworth's conference call will be accessible via telephone and internet. The dial-in number for Genworth's February 19 conference call is 888-208-1820 or 323-794-2110 (outside the U.S.); conference ID #5461958. To participat
Strategic Highlights Continued progress on the LTC1 multi-year rate action plan (MYRAP) with $124M of gross incremental premium approvals; approximately $30B estimated net present value achieved from in-force rate actions (IFAs) since 2012 Expanded the CareScout Quality Network to 49 states through October, covering over 75% of the aged 65-plus Census population in the United States; on track to achieve 80% to 85% coverage by year-end Executed $36M in share repurchases in the quarter; $144M executed year-to-date through October at an average price of $6.29 per share Repurchased $17M in principal of holding company debt at a discount Financial Highlights Net income2 of $85M, or $
UBS initiated coverage of Enact Holdings with a rating of Neutral and set a new price target of $29.00
BofA Securities upgraded Enact Holdings from Neutral to Buy and set a new price target of $30.00
BofA Securities upgraded Enact Holdings from Underperform to Neutral and set a new price target of $27.00 from $25.00 previously
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)
4 - Enact Holdings, Inc. (0001823529) (Issuer)